Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula
Launched by SOCIÉTÉ DES PRODUITS NESTLÉ (SPN) · Apr 27, 2015
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
The purpose of this study is to examine the tolerable and acceptability of an infant formula with with a Whey protein concentrate containing alpha-lactalbumin as measure by GI tolerance, and eating behaviors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Written informed consent
- • 2. Healthy, full term, singleton infant
- • 3. Be between 28±7 days post-natal age
- • 4. Infants at enrollment, weight-for-age ≥ 5th and ≤ 95th percentile according to World Health Organization growth tables / charts
- • 5. Infants must be exclusively consuming and tolerating a cow's milk infant formula for a minimum of 3 consecutive days and parent(s)/LAR must have previously made the decision to continue to exclusively formula feed
- • 6. Have sufficient command of Tagalog or English language to complete the informed consent and other study documents
- • 7. Are willing and able to fulfill the requirements of the study protocol
- • 8. Have reached the legal age of consent in the Philippines
- • 9. Able to be contacted by telephone throughout the study
- Exclusion Criteria:
- • 1. Infants who are receiving any amount of supplemental human milk
- • 2. Family history of siblings with documented cow's milk protein intolerance/allergy
- • 3. Conditions requiring infant feedings other than those specified in the protocol
Trial Officials
Elvira M Estorninos, MD
Principal Investigator
Asian Hospital and Medical Center
About Société Des Produits Nestlé (Spn)
Société des Produits Nestlé (SPN) is a global leader in nutrition, health, and wellness, dedicated to advancing scientific research and innovation in the food and beverage sector. As a subsidiary of Nestlé S.A., SPN focuses on developing high-quality products that promote healthier lifestyles and improve overall well-being. The organization actively sponsors clinical trials to evaluate the efficacy and safety of its nutritional offerings, collaborating with healthcare professionals and research institutions to gather valuable insights that inform product development and public health initiatives. Through its commitment to evidence-based research, SPN aims to enhance consumer trust and contribute to the advancement of nutritional science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alabang, Muntinlupa City, Philippines
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials